SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-004749
Filing Date
2017-03-20
Accepted
2017-03-20 07:00:18
Documents
16
Period of Report
2017-05-01
Effectiveness Date
2017-03-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A vtvt-def14a_20170501.htm DEF 14A 663785
2 GRAPHIC g2017031418593837735894.jpg GRAPHIC 667
3 GRAPHIC g2017031418593547035890.jpg GRAPHIC 2777
4 GRAPHIC g2017031418593837335891.jpg GRAPHIC 667
5 GRAPHIC g2017031418593531035889.jpg GRAPHIC 5766
6 GRAPHIC g2017031418593838535899.jpg GRAPHIC 684
7 GRAPHIC g2017031418593837535893.jpg GRAPHIC 684
8 GRAPHIC g2017031418594084435903.jpg GRAPHIC 41282
9 GRAPHIC g2017031418593838735900.jpg GRAPHIC 684
10 GRAPHIC g2017031418593838335898.jpg GRAPHIC 684
11 GRAPHIC g2017031418593837935895.jpg GRAPHIC 667
12 GRAPHIC g2017031418593838035896.jpg GRAPHIC 667
13 GRAPHIC g2017031418593838135897.jpg GRAPHIC 667
14 GRAPHIC g2017031418593838735901.jpg GRAPHIC 667
15 GRAPHIC g2017031418594082035902.jpg GRAPHIC 56264
16 GRAPHIC g2017031418593837535892.jpg GRAPHIC 667
  Complete submission text file 0001564590-17-004749.txt   823690
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 17700050
SIC: 2834 Pharmaceutical Preparations